Literature DB >> 9362444

Developmentally-regulated expression of murine K-ras isoforms.

S Pells1, M Divjak, P Romanowski, H Impey, N J Hawkins, A R Clarke, M L Hooper, D J Williamson.   

Abstract

The products (p21) of the three mammalian H-, N- and K-ras genes play important roles in intracellular signal transduction, linking membrane receptor kinases to the nuclear pathway through raf and mitogen activated protein kinase. They are involved in the regulation of proliferation and differentiation, and activating mutations of these genes are commonly associated with human cancers. Two p21 proteins are encoded by the K-ras gene (p21K-rasA and p21K-rasB) due to alternative splicing of the last exon. While the four p21ras proteins are highly homologous, their sequences diverge significantly at the C-termini, to which distinct biochemical and perhaps even functional differences may be ascribed. However, H-, N- and K-rasB appear to be ubiquitously expressed, with little evidence of tissue-specific or developmental regulation. In contrast, we now demonstrate that the expression of K-rasA is strikingly different. K-rasA is induced during differentiation of pluripotent embryonal stem cells in vitro. Its expression during early embryogenesis is limited temporally and spatially in a tissue-specific distribution which is largely maintained as an adult. This suggests a distinct biological role for p21K-rasA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362444     DOI: 10.1038/sj.onc.1201354

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

Review 1.  RAS-targeted therapies: is the undruggable drugged?

Authors:  Amanda R Moore; Scott C Rosenberg; Frank McCormick; Shiva Malek
Journal:  Nat Rev Drug Discov       Date:  2020-06-11       Impact factor: 84.694

2.  K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif.

Authors:  Frederick D Tsai; Mathew S Lopes; Mo Zhou; Helen Court; Odis Ponce; James J Fiordalisi; Jessica J Gierut; Adrienne D Cox; Kevin M Haigis; Mark R Philips
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-05       Impact factor: 11.205

3.  Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development.

Authors:  L M Esteban; C Vicario-Abejón; P Fernández-Salguero; A Fernández-Medarde; N Swaminathan; K Yienger; E Lopez; M Malumbres; R McKay; J M Ward; A Pellicer; E Santos
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

4.  Prognosis and clinical characteristics of colorectal cancer patients with KRAS gene mutation: a 5-year follow-up study.

Authors:  Dongyang Yang; Xiaorong Lai; Fei Xu; Ying Li; Weiwei Jiang; Dong Ma
Journal:  Int J Clin Exp Pathol       Date:  2019-02-01

Review 5.  RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.

Authors:  Bingliang Fang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-09-07       Impact factor: 3.848

Review 6.  The renewed battle against RAS-mutant cancers.

Authors:  Fuquan Zhang; Jit Kong Cheong
Journal:  Cell Mol Life Sci       Date:  2016-02-18       Impact factor: 9.261

7.  Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model.

Authors:  Heather S Floyd; Charles L Farnsworth; Nancy D Kock; Melissa C Mizesko; Joy L Little; Stephanie T Dance; Jeff Everitt; Jay Tichelaar; Jeffrey A Whitsett; Mark Steven Miller
Journal:  Carcinogenesis       Date:  2005-07-28       Impact factor: 4.944

8.  Activation of mitogen-activated protein kinase (mitogen-activated protein kinase/extracellular signal-regulated kinase) cascade by aldosterone.

Authors:  Eunan Hendron; James D Stockand
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

9.  Comparison of the Conformations of KRAS Isoforms, K-Ras4A and K-Ras4B, Points to Similarities and Significant Differences.

Authors:  Mayukh Chakrabarti; Hyunbum Jang; Ruth Nussinov
Journal:  J Phys Chem B       Date:  2016-01-27       Impact factor: 2.991

10.  P19 H-ras induces G1/S phase delay maintaining cells in a reversible quiescence state.

Authors:  Maria Camats; Mariette Kokolo; Kate J Heesom; Michael Ladomery; Montse Bach-Elias
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.